FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry, in particular to immunosuppressant. Immunosuppressant based on the extract of plants of the genus Astragalus, which is an aqueous extract of Astragalus vulpinus herb containing flavonoids, organic acids, saponins and polysaccharides, wt. %: flavonoids – 4.0–5.1; organic acids – 1.8–2.4; saponins – 9.0–10.4 and polysaccharides – 4.5–6.3.
EFFECT: above-described immunosuppressant has a pronounced immunotropic activity.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIOXIDANT AGENT | 2017 |
|
RU2677692C1 |
MEANS FOR CORRECTION OF PSYCHOEMOTICAL STATUS OF ORGANISM BASED ON ASTRAGALUS HERBS EXTRACT | 2016 |
|
RU2642595C1 |
AGENT WITH REGENERATING ACTION | 2018 |
|
RU2681652C1 |
VEGETAL ORIGIN AGENT IN FORM OF LIQUID EXTRACT HAVING ANTIFUNGAL ACTIVITY | 2019 |
|
RU2734247C2 |
EXTRACT OF ASTRAGALUS ROOTS | 2018 |
|
RU2706697C1 |
ANTI-BURN MEANS | 2018 |
|
RU2681851C1 |
ANTI-BURN AGENT | 2019 |
|
RU2703295C1 |
METHOD OF OBTAINING IMMUNOTROPIC PREPARATION AS BASE FOR MEDICATION "IMMUNOFLAN" | 2011 |
|
RU2491949C2 |
METHOD FOR INCREASING QUAIL PRODUCTIVITY | 2017 |
|
RU2700626C2 |
IMMUNOSTIMULATING DRUG | 2012 |
|
RU2510277C1 |
Authors
Dates
2018-09-11—Published
2017-12-06—Filed